{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.095,
  "market_cap": 227039592448,
  "revenue_ttm": 49601120257.99881,
  "net_income_ttm": 16309277961.65851,
  "ocf_ttm": 19454267133.126507,
  "capex_ttm": 9875181130.379297,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1395450444.9285066,
  "total_debt": 15907097796.260149,
  "cash_and_equivalents": 5120842645.242204,
  "book_value_ttm": 26701368261.242657,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4538531,
  "dividend_yield": 337.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-31T18:32:10Z"
}